News 2026
28.07.2026
Broad coalition to combat drug-resistant tuberculosis in Europe
Tuberculosis remains the world’s deadliest infectious disease caused by a single pathogen. In 2024, an estimated 10.7 million people worldwide developed tuberculosis, and 1.23 million died from the disease. The situation is particularly critical for drug-resistant tuberculosis: only around two in five affected individuals had access to treatment in 2024. Moreover, treatment outcomes remain substantially poorer than for drug-susceptible tuberculosis.
24.07.2026
Expertise Knows No Borders: Diana Udovenko Wins the BREATHE Final Quiz
The first online lecture series on infectious diseases organized as part of the BREATHE project concluded with an interactive “Infectious Diseases Jeopardy” quiz. Dr Diana Udovenko achieved the highest score and received a Littmann stethoscope in recognition of her quick and precise answers.
21.07.2026
Asthma: New Mechanism of Action Curbs Inflammatory Response
A team from the University of Bonn and the Research Center Borstel, Leibniz Lung Center (FZB) has discovered a previously unknown mechanism of action for a synthetic peptide that mitigates excessive inflammatory responses in allergic asthma. This mechanism specifically inhibits a key inflammatory switch in the immune system and opens up new avenues for treating chronic inflammatory diseases. The findings have now been published in the journal Advanced Science.
21.07.2026
New study finds high risk of tuberculosis among migrant children and adolescents arriving in Europe
An international research team led by scientists from the Research Center Borstel has published the first comprehensive systematic review and meta-analysis examining the risk of tuberculosis (TB) among migrant children and adolescents arriving in Europe.
20.07.2026
New Research Group strengthens Functional Microbiome Research at FZB
Prof. Dr. Amelia Barber has accepted the call to the W3 professorship for “Functional Microbiome Research in Chronic Lung Diseases” and since July 2026 is establishing a new research group at the Research Center Borstel, Leibniz Lung Center (FZB). With her expertise in fungal and microbiome research, she expands the scientific profile of FZB and builds a bridge between infection and chronic lung disease research.